Subject Injury. If a Study subject suffers an adverse reaction, illness, or injury which, in the reasonable judgment of Institution, was directly caused by a Study Drug or Study Device or any properly performed procedures required by the Protocol, Sponsor shall reimburse for the reasonable and necessary costs of diagnosis and treatment of any Study subject injury, including hospitalization, but only to the extent such expenses are not attributable to (i) Institution's negligence or willful misconduct or (ii) the natural progression of an underlying or pre-existing condition or events, unless exacerbated by participating in the Study.
Subject Injury. Sponsor shall reimburse Institution for the cost of providing necessary medical treatment to a Study subject for any injuries directly resulting from a Study subject’s participation in the Study, unless Institution’s negligence or misconduct caused the injury.
Subject Injury. If a Study subject suffers an adverse reaction, medical illness, or injury which was directly caused by a {CHOOSE: Study Drug or Study Device} and/or any properly performed procedures required by the Protocol, Sponsor shall reimburse for the reasonable and necessary expenses of diagnosis and treatment of any Study subject injury, including hospitalization, but only to the extent such adverse reaction, medical illness or injury are not directly caused by (i) Institution's negligence or willful misconduct; (ii) the natural progression of an underlying or pre-existing condition or events, unless exacerbated by participating in the Study; or (iii) Institution’s failure to adhere to and comply with the specifications of the Protocol and all reasonable written instructions furnished by Sponsor for the use and administration of any {CHOOSE: Study Drug or Study Device} used in the Study, provided that deviations from the Protocol and written instructions resulting from an imminent threat to the health or safety of a Study subject that do not cause the injury to the Study subject will not disqualify Institution from reimbursement under this provision.
Subject Injury. The Sponsor shall reimburse the Institution for the reasonable and necessary medical expenses incurred in treating any injury or illness to a Study Subject that are directly related to the administration of the Investigational Drug or the proper performance of any other Study procedure, each in accordance with the Protocol and the Sponsor’s written instructions to the Institution/Principal Investigator. The Sponsor is not required to provide compensation for (a) other injury- or illness-related costs (such as lost wages), (b) medical expenses that are paid for by a third party, (c) medical expenses that are incurred as the result of a violation of the Protocol or other misconduct or negligence, in each case by any agent or employee of the Institution (including the Study Staff), or (d) medical expenses for injury or illness unrelated to the Investigational Drug and unrelated to the proper performance of any other procedure required by the Protocol or Sponsor’s written instructions to the Institution/Principal Investigator, including, without limitation, medical expenses associated with a pre-existing medical condition or the progression of the underlying disease. 3.4
Subject Injury. A. V případě, že subjektu nastane újma přímým následkem jeho účasti v Klinickém hodnocení, jak bude společně stanoveno Zkoušejícím a Zadavatelem, bude Zdravotnické zařízení žádat o odpovídající úhradu všech souvisejících nákladů zdravotní péče pojišťovnu subjektu, plán řízené péče nebo jiný program výhod. Pokud budou náklady související s takovou újmou převyšovat rámec výdajů hrazených pojišťovnou subjektu, plánem řízené péče nebo jiným programem výhod, jak ověří Zdravotnické zařízení předtím, než bude předložen účet jakémukoli takovému plátci třetí strany, bude Zdravotnické zařízení žádat uhrazení těchto nákladů Zadavatele, Zadavatel však neposkytne žádné platby za náklady, které lze přisoudit: A. In the event that a subject is injured as a direct result of his or her participation in the Study, as determined jointly by Investigator and Sponsor, then Institution shall seek appropriate reimbursement for all related costs of care from the subject’s insurer, managed care plan, or other benefits program. If costs related to such an injury are outside the scope of covered benefits for a subject’s insurer, managed care plan, or other benefit program, as determined by Institution prior to a bill being submitted to any such third party payor, then Institution shall seek reimbursement from Sponsor for such costs; provided, however, that Sponsor shall not provide any payment for costs that are attributable to:
Subject Injury. As between the Parties, [***] shall not be liable to any Clinical Study subject for any injury, illness or side effect experienced or alleged to be experienced by such subject due to the subject’s participation in the Clinical Study, including any injury, illness or side effect caused by (a) any negligence or misconduct of [***], (b) [***], or (c) [***].
Subject Injury. Institution shall provide medical treatment to Study Subjects who suffer an adverse reaction or injury during the Study. Rigel shall reimburse Institution for the actual and reasonable costs of providing such medical treatment, to the extent the adverse reaction or injury was directly caused by the correct administration of the Study Drug or by the Protocol procedures. Xxxxx’x obligation to reimburse Institution shall not apply where such adverse reaction or injury is caused by the negligence or misconduct of Institution, Investigator or other Study Personnel, or where such adverse reaction or injury is caused by a pre-existing medical condition or underlying disease of the Study Subject.
Subject Injury. Sponsor agrees to assume responsibility for the reasonable costs of treatment of any adverse reaction and/or injury to a Study subject (“Subject Injury”) that results from any Study drugs and/or Products and/or any procedures required by a Protocol conducted during a Study in connection with this Agreement.
Subject Injury. (a) Company agrees to reimburse Institution for (or otherwise pay for) the costs of the care and treatment of any side effect, adverse reaction, illness, or injury to a subject resulting from a defect in the Study Drug.
Subject Injury. If a Study subject suffers an adverse reaction, illness, or injury which, in the reasonable judgment of Institution, was directly caused by a Study Drug administered in accordance with this Agreement and the Protocol or any properly performed procedures required by the Protocol, Sponsor shall provide reimbursement for the reasonable and necessary medical costs of diagnosis and medical treatment of any Study subject injury, including hospitalization, but only to the extent such expenses are not attributable to (I) Institution’s negligence or willful misconduct, (ii) Institution’s breach of this Agreement or (iii) the natural progression of an underlying or pre-existing condition or events, unless exacerbated by participating in the Study.
